Ultrasound, the decades-old technology known for providing early glimpses of unborn babies, could hold a key to a problem that has long challenged drug developers: getting drugs into hard-to-reach places to treat diseases like Alzheimer’s and cancer.
Copyright ©2023 Dow Jones & Company, Inc. All rights reserved. 87990cbe856818d5eddac44c7b1cdeb8